Genotyping of ABCC8, KCNJ11, and HADH in Iranian Infants with Congenital Hyperinsulinism
Table 1
Genotypes and pathogenicity prediction by using online prediction tools and the clinical significance according to Varsome.
Gene
Gender
Birth weight (gr)
Symptom onset
BS-INS at diagnosis
molecular diagnosis
Variant
Zygosity
GnomAD allele frequency
Iranome allele frequency
Clinical significance (varsome.com)
Family history
Surgery
Response to Diazoxide
Clinical Comments (patients did not response to diazoxide underwent surgery or other drugs)
ABCC8
F
4200
4D
27–47
1M
c.331G>A
Hom^
0.000008
—
Pathogenic
—
50D
—
Received diazoxide and octreotide before surgery and sirolimus for 3 months after surgery #
p.Gly111Arg
F
2600
1D
34–63
2.5M
c.2809C>T p.Leu937=
Hom^
—
—
Pathogenic
—
30D
—
Received diazoxide and sirolimus after surgery # histologic features: diffused islet hyperplasia
F
4350
3D
22–53
1M
c.1671+1G>A
Hom^
—
—
Pathogenic
—
57D
—
—
F
3400
3D
20–57
3M,6D
c.2041-21G>A
Hom^
0.00002
—
Likely Pathogenic
+∼
—
+
Received octreotide plus diazoxide in some weeks infancy,continued with diazoxide
M
4000
2D
25–33
1M,4D
+∼
2M
—
PET scan: no uptake in pancreas He died because of sepsis following the surgery
M
4200
1D
18–27
1M
+∼∼
—
—
Received diazoxide plus octreotide but lost follow up
F
3100
2D
28–69
4M
c.3438dup p.Thr1147HisfsTer48
Het (pat)∗
—
—
Pathogenic
—
2M
—
—
F
3000
4D
40–12
5M,22D
c.1109G>C p.Arg370Thr
Het (de novo)
—
—
Uncertain Significance
—
—
+
—
F
2800
3D
25–38
6Y,9M
c.3438dup p.Thr1147HisfsTer48
Het (pat)∗
—
—
Pathogenic
—
55D
—
Received insulin after surgery because of hyperglycemia
F
4200
1D
12–28
1M,2D
c.3151dup p.Cys1051LeufsTer64
Hom^
—
—
Pathogenic
—
—
—
Received diazoxide plus octreotide but lost follow up
M
3150
4D
32–54
1M
c.96C>G p.Asn32Lys
Comp-Het
—
—
Uncertain Significance
—
—
—
Received sirolimus and responded to sirolimus therapy #
c.2041-21G>A
0.00002
Uncertain Significance
M
2300
5D
44–34.6
3.5Y
c.3446G>A p.Cys1149Ty
Hom^
—
—
Likely Pathogenic
—
3.5Y
—
Received sirolimus plus diazoxide after surgery PET scan: avid lesion in the head of pancreas histologic features: islet cell hyperplasia
KCNJ11
F
3800
3D
28–44
1M,19D
c.287-288delinsTG p.Ala96Val
Hom^
—
—
Uncertain Significance
—
2M
—
—
F
3500
2D
36–65
2M
c.370T>A p.Ser124Thr
Hom^
—
—
Uncertain Significance
—
2M
—
Received sirulimus ,octreotide and diazoxide before surgery. Continued with low doses of diazoxide after surgery # Pet Scan :a mild uptake in the head of pancreas
F
4100
1D
28–28
22D
c.362T>G p.Phe121Cys
Hom^
—
—
Uncertain Significance
+∼∼
—
—
Did not responded to diazoxide alone , continued with octreotide and sirolimus #
HADH
M
3100
15D
38–14
1M
c.706C>T p.Arg236Ter
Hom^
0.00001
—
Pathogenic
—
—
+
PET scan: Uptake in the head of pancreas .Followed by pancreatectomy with no attacks of hypoglycemia
BS: Blood sugar (mg/dl); INS: insulin (IU/ml); D: day; M: Month; Y: year; Pat: paternal; Comp-Het: Compound heterozygote. # The patient previously reported from our center. ^ The mother and father are heterozygote for the variant. ∗ The mother did not have any variant in the three genes and the father was asymptomatic and carrying the variant. ∼ The patients are first cousins. ∼∼ The family had child with similar clinical manifestations but without genetic workups.